Germany · Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 49.04 billion. The enterprise value is 58.29 billion.
| Market Cap | 49.04B |
| Enterprise Value | 58.29B |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.73% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 16.59 and the forward PE ratio is 13.51. Merck KGaA's PEG ratio is 2.60.
| PE Ratio | 16.59 |
| Forward PE | 13.51 |
| PS Ratio | 2.31 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 14.85 |
| P/FCF Ratio | 21.33 |
| P/OCF Ratio | 12.67 |
| PEG Ratio | 2.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.10, with an EV/FCF ratio of 25.35.
| EV / Earnings | 19.72 |
| EV / Sales | 2.74 |
| EV / EBITDA | 10.10 |
| EV / EBIT | 13.65 |
| EV / FCF | 25.35 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.49 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 5.26 |
| Interest Coverage | 15.42 |
Financial Efficiency
Return on equity (ROE) is 10.32% and return on invested capital (ROIC) is 6.60%.
| Return on Equity (ROE) | 10.32% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 6.60% |
| Return on Capital Employed (ROCE) | 10.10% |
| Revenue Per Employee | 341,177 |
| Profits Per Employee | 47,413 |
| Employee Count | 59,020 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.96 |
Taxes
In the past 12 months, Merck KGaA has paid 756.00 million in taxes.
| Income Tax | 756.00M |
| Effective Tax Rate | 20.34% |
Stock Price Statistics
The stock price has decreased by -20.42% in the last 52 weeks. The beta is 0.73, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -20.42% |
| 50-Day Moving Average | 113.24 |
| 200-Day Moving Average | 117.03 |
| Relative Strength Index (RSI) | 49.05 |
| Average Volume (20 Days) | 354,986 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 21.27 billion and earned 2.96 billion in profits. Earnings per share was 6.80.
| Revenue | 21.27B |
| Gross Profit | 12.52B |
| Operating Income | 4.27B |
| Pretax Income | 3.72B |
| Net Income | 2.96B |
| EBITDA | 5.77B |
| EBIT | 4.27B |
| Earnings Per Share (EPS) | 6.80 |
Balance Sheet
The company has 2.92 billion in cash and 12.10 billion in debt, giving a net cash position of -9.18 billion or -21.11 per share.
| Cash & Cash Equivalents | 2.92B |
| Total Debt | 12.10B |
| Net Cash | -9.18B |
| Net Cash Per Share | -21.11 |
| Equity (Book Value) | 29.00B |
| Book Value Per Share | 66.41 |
| Working Capital | 4.24B |
Cash Flow
In the last 12 months, operating cash flow was 3.87 billion and capital expenditures -1.57 billion, giving a free cash flow of 2.30 billion.
| Operating Cash Flow | 3.87B |
| Capital Expenditures | -1.57B |
| Free Cash Flow | 2.30B |
| FCF Per Share | 5.29 |
Margins
Gross margin is 58.87%, with operating and profit margins of 20.07% and 13.90%.
| Gross Margin | 58.87% |
| Operating Margin | 20.07% |
| Pretax Margin | 17.47% |
| Profit Margin | 13.90% |
| EBITDA Margin | 27.13% |
| EBIT Margin | 20.07% |
| FCF Margin | 10.81% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.15% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 2.02% |
| Earnings Yield | 6.03% |
| FCF Yield | 4.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 2.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 7 |